Vancomycin Trough Near 15.9 mg/L Flags Nephrotoxicity Risk
Analysis Pharmacokinetics / TDM Confirmatory Grade: Low
Chen S, Zhang Y, Hou X, et al.
Jul 27, 2026 · Published in: Infection and Drug Resistance
Also in Infectious Disease / Antimicrobials, Nephrology
Vancomycin trough over 15.9 mg/L linked to kidney injury.
Terlipressin Linked to Lower In-Hospital Mortality in HRS-AKI
★ Editor's Pick Analysis Nephrology / Renal Pharmacy Hypothesis-generating Grade: Very Low
Johnson HN, Juang PA
Jul 25, 2026 · Published in: The Annals of Pharmacotherapy
Also in Gastroenterology / Hepatology
Terlipressin shows promise in lowering HRS-AKI mortality compared to standard treatments.
Positive Fluid Balance Linked to Severe AKI in Surgical ICU
Analysis Critical Care / ICU Hypothesis-generating Grade: Very Low
Nawaz S, Latif S
Jul 14, 2026 · Published in: JPMA. the Journal of the Pakistan Medical Association
Also in Nephrology
Fluid overload post-surgery may increase severe acute kidney injury risk.
Tirzepatide Cuts Major Kidney Events 23% Versus Dulaglutide in SURPASS-CVOT
Analysis Nephrology / Renal Pharmacy Hypothesis-generating Grade: Moderate
Zoungas S, D'Alessio D, Pavo I, et al.
Jul 11, 2026 · Published in: The Lancet. Diabetes & Endocrinology
Tirzepatide outshines dulaglutide in kidney protection for diabetes.
International Hypertension Guidelines in CKD: ESH, ESC, KDIGO, and AHA/ACC Compared
Guideline Nephrology / Renal Pharmacy Confirmatory Grade: Moderate
Stambolliu E, Stathopoulou E, Bora M, et al.
Jul 9, 2026 · Published in: Clinical Hypertension
Also in Cardiology
Navigating global hypertension guidelines in CKD can enhance patient care.
Dual NSAID Analgesia After Robotic Renal Surgery Shows No AKI Signal
Analysis Nephrology / Renal Pharmacy Hypothesis-generating Grade: Low
Song SH, Lee S, Ryu JH, et al.
Jul 6, 2026 · Published in: Investigative and Clinical Urology
Also in Perioperative / Anesthesia
Adding acetaminophen/ibuprofen to ketorolac PCA is safe for kidneys post-renal surgery.
Pharmacist Review Flags Drug Problems in CKD Patients Starting SGLT2 Inhibitors
Analysis Ambulatory Care / MTM Hypothesis-generating Grade: Very Low
Ozturk Yalcin Z, Erdut A, Haberal G, et al.
Jun 23, 2026 · Published in: Renal Failure
Also in Nephrology, Medication Safety
Pharmacist interventions reduce drug problems in CKD patients on SGLT2 inhibitors.
KDIGO Consensus Reframes Kidney-Heart Failure Comanagement Priorities
Analysis Oncology Pharmacy Confirmatory Grade: Low
Izzedine H, Perazella MA, Kuruvada KM, et al.
Jun 20, 2026 · Published in: Kidney International
Also in Nephrology
Preventing kidney damage in cancer treatment requires proactive strategies.
INFINITY: Finerenone Benefits Extend to Non-Diabetic Chronic Kidney Disease
★ Editor's Pick Analysis Nephrology / Renal Pharmacy Practice-changing Grade: Moderate
Neuen BL, Heerspink HJL, Perkovic V, et al.
Jun 13, 2026 · Published in: Lancet (London, England)
Finerenone cuts kidney decline risk by nearly a quarter.
New AHA/ACC/ADA/ASN Guideline Unifies Cardiovascular-Kidney-Metabolic Syndrome Management
★ Editor's Pick Guideline Cardiology Practice-changing Grade: High
Ndumele CE, Rodriguez F, Dixon DL, et al.
Jun 9, 2026 · Published in: Journal of the American College of Cardiology
Also in Nephrology, Endocrinology / Obesity
New guideline integrates cardiovascular, kidney, and metabolic care.
KDIGO Consensus Reframes Kidney Function Changes in Heart Failure
Analysis Nephrology / Renal Pharmacy Confirmatory Grade: Low
Lam CSP, Bozkurt B, Cherney DZI, et al.
Jun 6, 2026 · Published in: Kidney International
Also in Cardiology
CKD and HF coexistence demands integrated management strategies.
Active Pharmacist Ward Integration Outperforms Education in Renal Prescribing
Analysis Medication Safety Hypothesis-generating Grade: Low
Özmen Ö, Bektay MY, Karatoprak C, et al.
Jan 1, 2026 · Published in: Quasi-Experimental Study
Also in Nephrology
Pharmacist interventions cut drug-related issues by 30% in renal patients.
Finerenone Slows eGFR Decline in Non-Diabetic CKD
Analysis Nephrology / Renal Pharmacy Practice-changing Grade: Moderate
Heerspink HJL, Neuen BL, Agarwal R, et al.
Jan 1, 2026 · Published in: Unknown
Also in Cardiology
FIND-CKD extends the kidney-protective role of finerenone from diabetic to non-diabetic chronic kidney disease, giving pharmacists a new evidence-based add-on to renin-angiotensin system blockade.
KDIGO 2024 Chronic Kidney Disease Guideline: Precision CKD Care for Pharmacists
Guideline Nephrology / Renal Pharmacy Practice-changing Grade: Moderate
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group
Apr 1, 2024 · Published in: Kidney Int
The 2024 KDIGO guideline for CKD introduces new recommendations for screening, diagnosis, risk stratification, pharmacologic intervention, and bone-mineral disorder, with significant implications for pharmacist monitoring roles.